Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers

  • Yu, Helena A.; 
  • Ahn, Myung-Ju; 
  • Cho, Byoung Chul; 
  • Gerber, David E.; 
  • Natale, Ronald B.; 
  • 외 6명
Citations

WEB OF SCIENCE

10
Citations

SCOPUS

10

초록

Background: Dacomitinib is a second-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Pre-clinical data suggest that intermittent pulsatile dosing of dacomitinib may result in inhibition of EGFR T790M. Methods: We evaluated safety, pharmacokinetics and efficacy of intermittent pulsatile dacomitinib in both molecularly unselected patients and patients with lung cancers harboring EGFR T790M (Clinical Trial Registration Number NCT01858389). Results: Thirty-eight patients were treated on study with pulse dacomitinib; sixteen with EGFR T790M in Cohort A and 22 who were not molecularly selected in Cohort B. One patient out of 16 patients in Cohort A had a partial response to study therapy (ORR 6.3%, 95% CI 0.2-30.2%). The median progression-free survival (PFS) in Cohort A was 2.3 months and median PFS in Cohort B was 1.6 months. The adverse event profile was similar to standard daily dose dacomitinib with the most frequent treatment-related toxicities occurring in > 20% of patients being diarrhea, rash, stomatitis, nausea, dry skin, paronychia, fatigue, and decreased appetite. Conclusion: Intermittent pulsatile dacomitinib is safe and relatively well tolerated but is not effective in patients that harbor EGFR T790M or in unselected patients with non-small cell lung cancer.

키워드

Dacomitinib; Non-small-cell lung cancer; T790M; Egfr; Pulsatile dosing; Tyrosine kinase inhibitors; 1ST-LINE TREATMENT; OPEN-LABEL; ERLOTINIB; MUTATIONS; MULTICENTER; AFATINIB; ADENOCARCINOMA; CHEMOTHERAPY; RESISTANCE; INHIBITOR
제목
Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers
저자
Yu, Helena A.; Ahn, Myung-Ju; Cho, Byoung Chul; Gerber, David E.; Natale, Ronald B.; Socinski, Mark A.; Giri, Nagdeep; Quinn, Susan; Sbar, Eric; Zhang, Hui; Giaccone, Giuseppe
DOI
10.1016/j.lungcan.2017.08.017
발행일
2017-10
유형
Article
저널명
Lung Cancer
권
112
페이지
195 ~ 199